GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Return-on-Tangible-Asset

Phibro Animal Health (FRA:PB8) Return-on-Tangible-Asset : 3.86% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Phibro Animal Health's annualized Net Income for the quarter that ended in Mar. 2024 was €30.9 Mil. Phibro Animal Health's average total tangible assets for the quarter that ended in Mar. 2024 was €800.6 Mil. Therefore, Phibro Animal Health's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 3.86%.

The historical rank and industry rank for Phibro Animal Health's Return-on-Tangible-Asset or its related term are showing as below:

FRA:PB8' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -0.73   Med: 8.32   Max: 17.06
Current: 1.52

During the past 13 years, Phibro Animal Health's highest Return-on-Tangible-Asset was 17.06%. The lowest was -0.73%. And the median was 8.32%.

FRA:PB8's Return-on-Tangible-Asset is ranked worse than
51.06% of 1083 companies
in the Drug Manufacturers industry
Industry Median: 1.83 vs FRA:PB8: 1.52

Phibro Animal Health Return-on-Tangible-Asset Historical Data

The historical data trend for Phibro Animal Health's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Return-on-Tangible-Asset Chart

Phibro Animal Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.93 5.12 7.59 6.77 3.84

Phibro Animal Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.69 5.32 -3.75 0.58 3.86

Competitive Comparison of Phibro Animal Health's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Return-on-Tangible-Asset falls into.



Phibro Animal Health Return-on-Tangible-Asset Calculation

Phibro Animal Health's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=30.095/( (770.623+796.674)/ 2 )
=30.095/783.6485
=3.84 %

Phibro Animal Health's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=30.932/( (795.097+806.06)/ 2 )
=30.932/800.5785
=3.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Phibro Animal Health  (FRA:PB8) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Phibro Animal Health Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Phibro Animal Health (FRA:PB8) Business Description

Traded in Other Exchanges
Address
300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health (FRA:PB8) Headlines

No Headlines